Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00080418 · ClinicalTrials.gov registry record · Phase 1

Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer

A Phase 1 study of Neoplasm, sponsored by INSYS Therapeutics.

Completed
Registry status
Phase 1
Development phase
40
Enrollment target
3
Study locations

NCT00080418 is a Phase 1 study of Neoplasm that has completed, run by INSYS Therapeutics. The registered enrollment target is 40 participants, below the 199-participant average among 11 other Neoplasm trials with a reported enrollment target (80% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00080418, a Phase 1 study of Neoplasm, has completed, sponsored by INSYS Therapeutics.

COMPLETED
Registry status
Phase 1
Development phase
40 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to determine the highest dose of Liposome Entrapped Paclitaxel Easy to Use formulation (LEP-ETU) that can be safely administered by an intravenous infusion to patients with advanced cancer.

Conditions Studied

Neoplasm

Interventions

  • DRUG Liposome Entrapped Paclitaxel Easy to Use

Study Locations (3)

Florida

  • H. Lee Moffitt Cancer Center and Research Institute - Tampa

New Jersey

  • Cancer Institute of New Jersey - University of Medicine and Dentistry of New Jersey - New Brunswick

Pennsylvania

  • Fox Chase Temple Cancer Center - Temple University - Philadelphia

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2003-07
Est. Completion 2010-06
Phase Phase 1

Sponsor

INSYS Therapeutics

35 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00080418

The ClinicalTrials.gov registry entry for NCT00080418 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 199-participant average among 11 other Neoplasm trials with a reported enrollment target (80% lower). The listed sponsor is INSYS Therapeutics, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Liposome Entrapped Paclitaxel Easy to Use is the first listed.

NCT00080418 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, New Jersey, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00080418 about?

NCT00080418 is a clinical study titled "Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer". The purpose of this study is to determine the highest dose of Liposome Entrapped Paclitaxel Easy to Use formulation (LEP-ETU) that can be safely administered by an intravenous infusion to patients with advanced cancer.

What is the current status of trial NCT00080418?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2003-07. Estimated completion is 2010-06.

What conditions does trial NCT00080418 study?

This clinical trial studies the following conditions: Neoplasm.

What interventions are being tested in trial NCT00080418?

The interventions under investigation include: Liposome Entrapped Paclitaxel Easy to Use (DRUG).

Who is sponsoring clinical trial NCT00080418?

This trial is sponsored by INSYS Therapeutics, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00080418 being conducted?

This trial has 3 study locations across Florida, New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Neoplasm

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.